To assess the effectiveness of proton vs. photon therapy in reducing major cardiovascular events (MCE), defined as atherosclerotic coronary heart disease or other heart disease death, myocardial infarction, coronary revascularization, or hospitalization for major cardiovascular event (heart failure, valvular disease, arrhythmia, or unstable angina).
Clinical Trial Information
Trial Contact: Ferry, Robert, P.; Ford, Elizabeth
Age Group: Adult
Phase: Drug: Phase III
Principal Investigator: Tomas Dvorak, MD
IRB No: 16.126.10.
Secondary Protocol No: RADCOMP
Applicable Disease Sites: Breast Cancer